| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,025 | 8,297 | 8,310 | 8,513 | | Cost of Revenue | 73 | 19 | 94 | 50 | | | Gross Profit | 38,952 | 8,277 | 8,216 | 8,462 | | | Operating Expenses | | Research Development | 5,533 | 4,420 | 5,875 | 5,581 | | Selling General and Administrative | 1,650 | 1,413 | 1,391 | 1,400 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,768 | 2,444 | 949 | 1,481 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 285 | (1,437) | (111) | 81 | | Earnings Before Interest And Taxes | 32,053 | 1,007 | 839 | 1,562 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 32,053 | 1,007 | 839 | 1,562 | | Income Tax Expense | 41 | 153 | 81 | (1,330) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 32,012 | 855 | 758 | 2,892 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 32,012 | 855 | 758 | 2,892 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $32,012 | $855 | $758 | $2,892 |
|
0.01% Nasdaq 0.00%
Income Statement
